Premium
Halozyme Therapeutics Inc (0J2O)
LSE
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -46.48 | 16.116 | -16.732 | -14.36 | 22.532 | 47.818 | 13.723 | 15.754 |
| Return on Equity (%) | -1958.985 | 71.605 | -35.136 | -42.413 | 106.325 | 231.443 | 110.227 | 222.072 |
| Return on Invested Capital (%) | -73.086 | 33.357 | -23.048 | -18.219 | 48.036 | 90.275 | 21.951 | 22.224 |
| Operating Margin (%) | -55.821 | 26.403 | -40.663 | -30.932 | 55.935 | 57.757 | 40.275 | 44.268 |
| Net Profit Margin (%) | -70.231 | 19.889 | -52.897 | -36.859 | 48.239 | 90.842 | 30.62 | 33.958 |
| Book Value Per Share | -0.236 | 1.38 | 1.628 | 0.633 | 1.055 | 1.352 | -5.482 | -5.744 |
| Earnings Per Share | -0.748 | 0.417 | -0.525 | -0.499 | 0.901 | 2.764 | 1.41 | 2.007 |
| Cash Per Share | 0.485 | 1.118 | 0.379 | 0.829 | 1.031 | 0.815 | 1.634 | 0.844 |
| Working Capital Per Share | 1.467 | 2.51 | 1.821 | 3.159 | 0.931 | 5.554 | 4.243 | 4.519 |
| Operating Profit Per Share | 0.842 | 1.905 | 0.942 | 1.066 | 1.588 | 2.505 | 3.678 | 4.619 |
| EBIT Per Share | -0.74 | 0.408 | -0.522 | -0.499 | 0.903 | 1.706 | 1.736 | 2.483 |
| EBITDA Per Share | -0.74 | 0.408 | -0.522 | -0.499 | 0.903 | 1.706 | 1.736 | 2.483 |
| Free Cash Flow Per Share | -0.743 | 0.412 | -0.51 | -0.499 | 0.896 | 2.754 | 1.097 | 1.511 |
| Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 129,5M | 142,79M | 144,73M | 136,71M | 135,03M | 137,5M | 135,15M | N/A |
| Capitalisation boursière | 2,41B |
| Ratio cours/bénéfice | 22,82 |
| Ratio prix/ventes | 7,75 |
| Ratio prix/liquidités | 54,29 |
| Ratio prix/valeur comptable | 76,68 |
| Rendement de dividende | - |
| Actions en circulation | 132,1M |
| Volume moyen (1 semaine) | 1,12k |
| Volume moyen (1 mois) | 2,75k |
| Variation sur 52 semaines | 0,00% |
| Plus haut sur 52 semaines | 18,26 |
| Plus bas sur 52 semaines | 18,26 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
